WallStSmart

BlackRock Inc (BLK)vsHelius Medical Technologies Inc Class A (HSDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BlackRock Inc generates 226035% more annual revenue ($27.30B vs $12.07M). BLK leads profitability with a 24.1% profit margin vs 0.0%. HSDT trades at a lower P/E of 0.0x. BLK earns a higher WallStSmart Score of 78/100 (B+).

BLK

Strong Buy

78

out of 100

Grade: B+

Growth: 8.7Profit: 7.5Value: 6.3Quality: 5.0
Piotroski: 1/9Altman Z: 1.11

HSDT

Avoid

34

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 6.7Quality: 7.8
Piotroski: 4/9Altman Z: 58.58

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BLK6 strengths · Avg: 9.2/10
Operating MarginProfitability
35.1%10/10

Strong operational efficiency at 35.1%

Revenue GrowthGrowth
30.6%10/10

Revenue surging 30.6% year-over-year

Market CapQuality
$175.42B9/10

Large-cap with strong market position

Profit MarginProfitability
24.1%9/10

Keeps 24 of every $100 in revenue as profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.898/10

Growing faster than its price suggests

HSDT4 strengths · Avg: 10.0/10
P/E RatioValuation
0.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
5774.0%10/10

Revenue surging 5774.0% year-over-year

Altman Z-ScoreHealth
58.5810/10

Safe zone — low bankruptcy risk

Areas to Watch

BLK3 concerns · Avg: 3.0/10
P/E RatioValuation
25.4x4/10

Moderate valuation

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.112/10

Distress zone — elevated risk

HSDT4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$125.75M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-137.4%2/10

ROE of -137.4% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : BLK

The strongest argument for BLK centers on Operating Margin, Revenue Growth, Market Cap. Profitability is solid with margins at 24.1% and operating margin at 35.1%. Revenue growth of 30.6% demonstrates continued momentum.

Bull Case : HSDT

The strongest argument for HSDT centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 5774.0% demonstrates continued momentum.

Bear Case : BLK

The primary concerns for BLK are P/E Ratio, Piotroski F-Score, Altman Z-Score.

Bear Case : HSDT

The primary concerns for HSDT are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

BLK profiles as a growth stock while HSDT is a hypergrowth play — different risk/reward profiles.

BLK carries more volatility with a beta of 1.43 — expect wider price swings.

HSDT is growing revenue faster at 5774.0% — sustainability is the question.

BLK generates stronger free cash flow (32M), providing more financial flexibility.

Bottom Line

BLK scores higher overall (78/100 vs 34/100), backed by strong 24.1% margins and 30.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BlackRock Inc

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

BlackRock, Inc. is an American multinational investment management corporation based in New York City.

Helius Medical Technologies Inc Class A

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.

Want to dig deeper into these stocks?